Bio-Rad Laboratories | BIO - 市值



金融业
股票价格
USD
资产
USD 10.58B
现金及等价物
USD 529.8M
销售成本
USD 309.6M
流动资产
USD 2.91B
流动负债
USD 517M
债务
USD 1.4B
EBIT
USD -418.8M
EBITDA
USD -374.6M
员工
8.03K
EPS每股收益
USD 2.51
股本和储备
USD 7.45B
销售毛利
USD 343.4M
债务利息支出
USD 12.3M
利息收入
USD 13.7M
贷款资金
USD 1.2B
市值
USD 6.34B
净收入
USD -341.9M
营业费用
USD 6.74B
营业利润
USD 63.9M
普通股股本
USD 26.97M
PE价格收益
16.42
税前利润
USD 82.9M
销售收入
USD 693.2M
销售和管理费用
USD 206.8M
股票
USD 740.7M
贸易债权人
USD 129M
应收帐款人
USD 464.7M


市值 更改 日
Abbott USD 217.86B 15.25B 2025-12
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio Techne USD 9.16B 502M 2025-12
Bio-Rad Laboratories USD 6.16B 2.05B 2026-03
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 161.7B 29.34B 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Hologic USD 16.62B 1.67B 2025-12
Illumina USD 20.62B 6.53B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Merck USD 261.26B 51.62B 2025-12
Mettler Toledo International USD 25.68B 2.8B 2026-03
Myriad Genetics USD 417M 158M 2026-03
OraSure Technologies USD 219M 45M 2026-03
Pacific Biosciences Of California USD 356M 209M 2026-03
Quest Diagnostics USD 19.3B 2.01B 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Siemens EUR 172.18B 19.14B 2026-03
Standard Biotools USD 357M 135M 2026-03
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Tosoh JPY 773.98B 9.39B 2026-03
Waters USD 22.61B 5.25B 2025-12